COVID-19 and T cells: Single-cell transcriptomic analysis of SARS-CoV-2-reactive CD8 + and CD4 + T cells.

 

As the SARS-CoV-2 related disease COVID-19 hit hard and changed the lives of every person on earth, the Vijayanand lab recently started to put their expertise in single-cell analysis of T cells responding to SARS-CoV-2 and other respiratory viruses.

Selected References

Meckiff BJ, Ramírez-Suástegui C, Fajardo V, Chee SJ, Kusnadi A, Simon H, Grifoni A, Pelosi E, Weiskopf D, Sette A, Ay F, Seumois G, Ottensmeier CH, Vijayanand P. Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4 + T cells. bioRxiv. 2020 Jun 13:2020.06.12.148916. doi:10.1101/2020.06.12.148916. Preprint. PMID: 32587963

Kusnadi A, Ramírez-Suástegui C, Fajardo V, Chee SJ, Meckiff BJ, Simon H, Pelosi E, Seumois G, Ay F, Vijayanand P*, Ottensmeier CH*. *corresponding authors. Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8 + T cells. bioRxiv. 2020 Jul 10:2020.07.09.194027. doi: 10.1101/2020.07.09.194027. Preprint. – under review Nature Biotechnology.

Grants

NIH/NIAID, U19AI14273-S1
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses

NIH/NIAID, U19AI142742-02
Cooperative Centers on Human Immunology: Biology of human cytotoxic cd4 t cells (CD4-CTLs) in viral infections

About La Jolla Institute

The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease. Visit lji.org for more information.

Share this Article:

LJI Professor Sujan Shresta, Ph.D., is a leader in dengue virus research and vaccine development
LJI and Synbal, Inc. scientists develop new tool for pandemic preparedness